Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
The Journal of Biological Chemistry
|
November 5, 1997
Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein
R Hofmeister, K Wiegmann, C Korherr, et al.
The Journal of Biological Chemistry
|
May 13, 1994
Sphingomyelinase activates proteolytic I kappa B-alpha degradation in a cell-free system
T Machleidt, K Wiegmann, T Henkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1990
Regulation of IFN-gamma-receptor expression in human monocytes by granulocyte-macrophage colony-stimulating factor
T Fischer, K Wiegmann, H Böttinger, et al.
Cell
|
November 27, 1992
TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
S Schütze, K Potthoff, T Machleidt, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades
K Wiegmann, S Schütze, E Kampen, et al.
International Journal of Immunopharmacology
|
November 1, 1995
Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist-treated rats
S Muthyala, K Wiegmann, D H Kim, et al.
Journal of Autoimmunity
|
October 20, 1998
Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats
E Chelmicka-Schorr, K Wiegmann, R Wollmann, et al.
Journal of Neuroimmunology
|
February 1, 1995
Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats
K Wiegmann, S Muthyala, D H Kim, et al.
The Journal of Biological Chemistry
|
February 20, 1999
Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase
K Wiegmann, R Schwandner, O Krut, et al.
The Journal of Experimental Medicine
|
August 1, 1996
Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C
T Machleidt, B Krämer, D Adam, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
The Journal of Biological Chemistry
|
November 5, 1997
Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein
R Hofmeister, K Wiegmann, C Korherr, et al.
The Journal of Biological Chemistry
|
May 13, 1994
Sphingomyelinase activates proteolytic I kappa B-alpha degradation in a cell-free system
T Machleidt, K Wiegmann, T Henkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1990
Regulation of IFN-gamma-receptor expression in human monocytes by granulocyte-macrophage colony-stimulating factor
T Fischer, K Wiegmann, H Böttinger, et al.
Cell
|
November 27, 1992
TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
S Schütze, K Potthoff, T Machleidt, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades
K Wiegmann, S Schütze, E Kampen, et al.
International Journal of Immunopharmacology
|
November 1, 1995
Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist-treated rats
S Muthyala, K Wiegmann, D H Kim, et al.
Journal of Autoimmunity
|
October 20, 1998
Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats
E Chelmicka-Schorr, K Wiegmann, R Wollmann, et al.
Journal of Neuroimmunology
|
February 1, 1995
Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats
K Wiegmann, S Muthyala, D H Kim, et al.
The Journal of Biological Chemistry
|
February 20, 1999
Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase
K Wiegmann, R Schwandner, O Krut, et al.
The Journal of Experimental Medicine
|
August 1, 1996
Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C
T Machleidt, B Krämer, D Adam, et al.
Page
of 4